Evidence map›Paper›PMID 33078220›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Multi-year prevalence and macrolide resistance of Mycoplasma genitalium in clinical samples from a southern Italian hospital.

Abbasciano Angela, Del Prete Raffaele, Romanelli Federica, Mosca Adriana, Santacroce Luigi, Ronga Luigi

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Drug resistance ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Estimation of antimicrobial resistance ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  3. Review
  4. Frontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Abbasciano AngelaDip DIM, Università degli Studi, Policlinico, P.zza G. Cesare, 4, 70124, Bari, Italy.
Del Prete RaffaeleDip DIM, Università degli Studi, Policlinico, P.zza G. Cesare, 4, 70124, Bari, Italy.
Romanelli FedericaDip DIM, Università degli Studi, Policlinico, P.zza G. Cesare, 4, 70124, Bari, Italy.
Mosca AdrianaDip DIM, Università degli Studi, Policlinico, P.zza G. Cesare, 4, 70124, Bari, Italy.
Santacroce LuigiDip DIM, Università degli Studi, Policlinico, P.zza G. Cesare, 4, 70124, Bari, Italy.
Ronga LuigiUOC Microbiologia e Virologia, Azienda Ospedaliero-Universitaria Policlinico, P.zza G. Cesare, 4, 70124, Bari, Italy. rongalu@yahoo.it.
Ospedale Pediatrico Giovanni XXIII · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of azithromycin for the treatment of Mycoplasma genitalium infections has led to resistance to macrolides. From July 2014 to July 2020, 7150 samples were analysed for the detection of sexually transmitted infections at the Policlinico of Bari. A total of 67/7150 samples (0.93%) were positive for MG DNA and 47 samples were analysed for the evaluation of six azithromycin resistance-associated mutations. In 5/47 samples, the A2058G mutation was detected (10.63%). Although the cases of positive MG samples and mutations are low in our reality, diagnostic tests to detect azithromycin resistant-associated genes may provide a convenient way to monitor resistance rate.

Indexed as

Anti-Bacterial AgentsAzithromycinDrug Resistance, Multiple, BacterialHospitalsHumansItalyMycoplasma genitaliumMycoplasma InfectionsPrevalenceSexually Transmitted Diseases, BacterialAnti-Bacterial AgentsAzithromycinAzithromycin resistanceEpidemiologyMultiplex real-time PCRMycoplasma genitaliumSurveillance

Identifiers

PMID33078220
OpenAlexW3093460862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.